Literature DB >> 17391399

Identification of a novel bla(OXA-51) variant, bla(OXA-92), from a clinical isolate of Acinetobacter baumannii.

A Tsakris, A Ikonomidis, N Spanakis, S Pournaras, K Bethimouti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17391399     DOI： 10.1111/j.1469-0691.2006.01598.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   8.067


× No keyword cloud information.
  7 in total

Review 1.  Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside.

Authors:  Ming-Feng Lin; Chung-Yu Lan
Journal:  World J Clin Cases       Date:  2014-12-16       Impact factor: 1.337

2.  Single-locus-sequence-based typing of blaOXA-51-like genes for rapid assignment of Acinetobacter baumannii clinical isolates to international clonal lineages.

Authors:  Spyros Pournaras; Vasiliki Gogou; Maria Giannouli; Evangelia Dimitroulia; Konstantina Dafopoulou; Athanasios Tsakris; Raffaele Zarrilli
Journal:  J Clin Microbiol       Date:  2014-03-12       Impact factor: 5.948

Review 3.  OXA β-lactamases.

Authors:  Benjamin A Evans; Sebastian G B Amyes
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

Review 4.  Diversity, epidemiology, and genetics of class D beta-lactamases.

Authors:  Laurent Poirel; Thierry Naas; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2009-08-31       Impact factor: 5.191

Review 5.  Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options.

Authors:  Chang-Ro Lee; Jung Hun Lee; Moonhee Park; Kwang Seung Park; Il Kwon Bae; Young Bae Kim; Chang-Jun Cha; Byeong Chul Jeong; Sang Hee Lee
Journal:  Front Cell Infect Microbiol       Date:  2017-03-13       Impact factor: 5.293

Review 6.  Carbapenemases: Transforming Acinetobacter baumannii into a Yet More Dangerous Menace.

Authors:  Maria Soledad Ramirez; Robert A Bonomo; Marcelo E Tolmasky
Journal:  Biomolecules       Date:  2020-05-06

7.  In vitro activity of tigecycline and comparators against carbapenem-susceptible and resistant Acinetobacter baumannii clinical isolates in Italy.

Authors:  Maria Lina Mezzatesta; Giusi Trovato; Floriana Gona; Vito Mar Nicolosi; Daria Nicolosi; Alessandra Carattoli; Giovanni Fadda; Giuseppe Nicoletti; Stefania Stefani
Journal:  Ann Clin Microbiol Antimicrob       Date:  2008-02-08       Impact factor: 3.944
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.